Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Nolan, Jason M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S511000
Reexamination Certificate
active
07968589
ABSTRACT:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
REFERENCES:
patent: 5776954 (1998-07-01), deLaszlo et al.
patent: 6503949 (2003-01-01), Lau et al.
patent: 6765009 (2004-07-01), Francesco et al.
patent: 7186746 (2007-03-01), Acton, III et al.
patent: 7345085 (2008-03-01), Acton, III et al.
patent: 7598398 (2009-10-01), Kim et al.
patent: 7687534 (2010-03-01), Stelmach et al.
patent: 2003/0158226 (2003-08-01), Belloni et al.
patent: 2010/0004158 (2010-01-01), Stelmach et al.
patent: 1 489 077 (2004-12-01), None
patent: 97/16442 (1997-05-01), None
patent: 98/04528 (1998-02-01), None
patent: 98/21957 (1998-05-01), None
patent: 98/22108 (1998-05-01), None
patent: 98/22109 (1998-05-01), None
patent: 99/01423 (1999-01-01), None
patent: 99/32448 (1999-07-01), None
patent: 00/39088 (2000-07-01), None
patent: 00/69810 (2000-11-01), None
patent: 02/00612 (2002-01-01), None
patent: 03/048109 (2003-06-01), None
patent: 03/051357 (2003-06-01), None
patent: 03/053938 (2003-07-01), None
patent: 03/064404 (2003-08-01), None
patent: 03/097619 (2003-11-01), None
patent: 2004/002480 (2004-01-01), None
patent: 02/40444 (2005-05-01), None
patent: 2006/102067 (2006-09-01), None
Kahn et al. Nature 2006, 444(14), 840-846.
GlaxoSmithKline, “Glucagon Receptor Antagonists for the Treatment of Type 2 Diabetes”, 226th ACS National Meeting, Abs. MEDI-164 (2003).
R. Kurukulasuriya et al., “Biaryl Amide Glucagon Receptor Antagonists”, Bioorganic & Medicinal Chemistry Letters, vol. 14, pp. 2047-2050 (2004).
Byrn et al., Solid-State Chemistry of Drugs, 2d, Chapter 11 Hydrates and Solvates, 233-247, 1999.
Morissette et al., Advanced Drug Delivery Rev., (2004), 56, 275-300.
A. M. Rouhi, Chem. & Eng. News, (Feb. 24, 2003), 81(8), 32-35.
Ling et al., Expert Opin. Ther. Patents, (2003), 13(1), 15-22.
Sloop et al., Expert Opin. Ther. Targets, (2005), 9(3), 593-600.
Bittner Amy R.
Chang Jiang
Kim Ronald M.
Parmee Emma R.
Rosauer Keith G.
Billups Richard C.
Merck Sharp & Dohme Corp.
Nolan Jason M
Struse Heidi M.
LandOfFree
Glucagon receptor antagonist compounds, compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon receptor antagonist compounds, compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonist compounds, compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2694258